» Articles » PMID: 28196062

Elemene Induces Apoptosis of Human Gastric Cancer Cell Line BGC-823 Via Extracellular Signal-Regulated Kinase (ERK) 1/2 Signaling Pathway

Overview
Journal Med Sci Monit
Date 2017 Feb 15
PMID 28196062
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

BACKGROUND Elemene is extracted from a traditional herbal medicine and is commonly used in the treatment of cancer in China. However, its effect on gastric cancer cells remains unknown. The goal of this study was to investigate its effect on human gastric cancer cells. MATERIAL AND METHODS Human gastric cancer BGC-823 cells and a tumor-bearing mouse model were employed to be divided into 4 groups: control group, elemene group, PD98059 group (an ERK 1/2 signaling pathway inhibitor), and the combined group (elemene plus PD98059). The tumor size, cell proliferation, expression of ERK 1/2 and phosphorylated ERK 1/2 (p-ERK 1/2), Bcl-2 mRNA, and Bax mRNA were measured. Moreover, cell apoptosis was detected and the apoptosis index was calculated. RESULTS Elemene and PD98059 each significantly inhibited the proliferation of gastric cancer cells BGC-823, and their combination showed higher synergistic inhibitory effect (P<0.05). We also found increased expression levels of p-ERK l/2 protein and Bax mRNA, but reduced level of Bcl-2 mRNA expression (P<0.05). Elemene presented higher apoptosis rate in a dose-dependent manner (P<0.05). Furthermore, the injection of elemene decreased the weight of transplanted tumors. CONCLUSIONS Elemene can inhibit the proliferation and induce the apoptosis of gastric cancer cells associated with the ERK 1/2 signaling pathway and expression levels of Bax mRNA and Bcl-2 mRNA.

Citing Articles

Synergistic effects of bevacizumab in combination with β-elemene on subcutaneous xenografts derived from HCT-116 human colon cancer cells.

Li J, Xie F, Wang Y Transl Cancer Res. 2022; 9(2):1001-1011.

PMID: 35117445 PMC: 8798753. DOI: 10.21037/tcr.2019.12.35.


Potential of Bioactive Food Components against Gastric Cancer: Insights into Molecular Mechanism and Therapeutic Targets.

Kang S, Hwang D, Shin S, Park J, Kim M, Rahman M Cancers (Basel). 2021; 13(18).

PMID: 34572730 PMC: 8469857. DOI: 10.3390/cancers13184502.


β-elemene inhibits non-small cell lung cancer cell migration and invasion by inactivating the FAK-Src pathway.

Zhang H, Li S, Bao J, Ge N, Hong F, Qian L Exp Ther Med. 2021; 22(4):1095.

PMID: 34504549 PMC: 8383758. DOI: 10.3892/etm.2021.10529.


β-Elemene Enhances the Chemotherapeutic Effect of 5-Fluorouracil in Triple-Negative Breast Cancer via PI3K/AKT, RAF-MEK-ErK, and NF-κB Signaling Pathways.

Su P, Ahmad B, Zou K, Zou L Onco Targets Ther. 2020; 13:5207-5222.

PMID: 32606741 PMC: 7294576. DOI: 10.2147/OTT.S242820.


ERα36 is an effective target of epigallocatechin-3-gallate in hepatocellular carcinoma.

Chen J, Chen L, Lu T, Xie Y, Li C, Jia Z Int J Clin Exp Pathol. 2020; 12(9):3222-3234.

PMID: 31934166 PMC: 6949832.


References
1.
Xu H, Li L, Fu J, Mao X, Xu L . Reversion of multidrug resistance in a chemoresistant human breast cancer cell line by β-elemene. Pharmacology. 2012; 89(5-6):303-12. DOI: 10.1159/000337178. View

2.
Roux P, Blenis J . ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol Mol Biol Rev. 2004; 68(2):320-44. PMC: 419926. DOI: 10.1128/MMBR.68.2.320-344.2004. View

3.
Jemal A, Murray T, Ward E, Samuels A, Tiwari R, Ghafoor A . Cancer statistics, 2005. CA Cancer J Clin. 2005; 55(1):10-30. DOI: 10.3322/canjclin.55.1.10. View

4.
Kohno M, Pouyssegur J . Pharmacological inhibitors of the ERK signaling pathway: application as anticancer drugs. Prog Cell Cycle Res. 2003; 5:219-24. View

5.
Yang E, Korsmeyer S . Molecular thanatopsis: a discourse on the BCL2 family and cell death. Blood. 1996; 88(2):386-401. View